KR20170117246A - 내피 모방 나노매트릭스 - Google Patents

내피 모방 나노매트릭스 Download PDF

Info

Publication number
KR20170117246A
KR20170117246A KR1020177029163A KR20177029163A KR20170117246A KR 20170117246 A KR20170117246 A KR 20170117246A KR 1020177029163 A KR1020177029163 A KR 1020177029163A KR 20177029163 A KR20177029163 A KR 20177029163A KR 20170117246 A KR20170117246 A KR 20170117246A
Authority
KR
South Korea
Prior art keywords
sequence
peptide
seq
cell adhesion
nitric oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020177029163A
Other languages
English (en)
Korean (ko)
Inventor
호욱 전
미낙시 쿠샤와하
브리지타 씨. 브로트
피터 앤더슨
Original Assignee
유에이비 리서치 파운데이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유에이비 리서치 파운데이션 filed Critical 유에이비 리서치 파운데이션
Publication of KR20170117246A publication Critical patent/KR20170117246A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
    • D06M16/003—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic with enzymes or microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
    • D06M2101/16—Synthetic fibres, other than mineral fibres
    • D06M2101/30—Synthetic polymers consisting of macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M2101/32—Polyesters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Textile Engineering (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020177029163A 2008-11-07 2009-11-09 내피 모방 나노매트릭스 Ceased KR20170117246A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11257808P 2008-11-07 2008-11-07
US61/112,578 2008-11-07
US12/497,305 2009-07-02
US12/497,305 US8735354B2 (en) 2008-11-07 2009-07-02 Endothelium mimicking nanomatrix
PCT/US2009/063732 WO2010054316A2 (en) 2008-11-07 2009-11-09 Endothelium mimicking nanomatrix

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020117013015A Division KR101822200B1 (ko) 2008-11-07 2009-11-09 내피 모방 나노매트릭스

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020187033168A Division KR20180125627A (ko) 2008-11-07 2009-11-09 내피 모방 나노매트릭스

Publications (1)

Publication Number Publication Date
KR20170117246A true KR20170117246A (ko) 2017-10-20

Family

ID=42153619

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020177029163A Ceased KR20170117246A (ko) 2008-11-07 2009-11-09 내피 모방 나노매트릭스
KR1020187033168A Ceased KR20180125627A (ko) 2008-11-07 2009-11-09 내피 모방 나노매트릭스
KR1020117013015A Active KR101822200B1 (ko) 2008-11-07 2009-11-09 내피 모방 나노매트릭스

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020187033168A Ceased KR20180125627A (ko) 2008-11-07 2009-11-09 내피 모방 나노매트릭스
KR1020117013015A Active KR101822200B1 (ko) 2008-11-07 2009-11-09 내피 모방 나노매트릭스

Country Status (9)

Country Link
US (1) US8735354B2 (https=)
EP (1) EP2365820B1 (https=)
JP (1) JP5693458B2 (https=)
KR (3) KR20170117246A (https=)
CN (1) CN102355904A (https=)
AU (1) AU2009313243B2 (https=)
CA (1) CA2742782C (https=)
ES (1) ES2699459T3 (https=)
WO (1) WO2010054316A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8735354B2 (en) 2008-11-07 2014-05-27 Uab Research Foundation Endothelium mimicking nanomatrix
JP5792442B2 (ja) * 2010-09-01 2015-10-14 帝人株式会社 細胞特異的ペプチドを含有する繊維構造体
WO2013065814A1 (ja) * 2011-11-04 2013-05-10 ニプロ株式会社 注射針
US20150037293A1 (en) * 2012-03-06 2015-02-05 The Uab Research Foundation Technologies for pancreatic islet transplantation
CA2899477C (en) 2013-02-07 2019-09-17 The Regents Of The University Of Michigan Thromboresistant/bactericidal s-nitroso-n-acetylpenicillamine (snap)-doped nitric oxide release polymers with enhanced stability
US9517275B2 (en) * 2013-09-30 2016-12-13 Northwestern University Targeted therapy for the prevention of restenosis in the cardiovascular system
US20150335685A1 (en) * 2014-05-20 2015-11-26 Emory University Engineered stem cell therapy for cardiac repair
EP3362079B1 (en) 2015-10-14 2022-04-06 Northwestern University Nanofiber paste for growth factor delivery and bone regeneration
US12344863B2 (en) 2016-11-07 2025-07-01 Emory University Method of producing stem cell-derived endothelial cells and uses thereof
CN107034586A (zh) * 2017-04-21 2017-08-11 天津工业大学 一种聚羟基丁酸酯/聚吡咯复合导电纳米纤维膜及其制备方法
CN112891625A (zh) * 2021-02-01 2021-06-04 南方医科大学南方医院 一种聚多巴胺二次聚合胶原海绵支架及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002513400A (ja) * 1997-02-06 2002-05-08 デューク ユニバーシティ メディカル センター Ｎｏ修飾ヘモグロビンおよびそのための使用
US7713923B2 (en) 2003-06-25 2010-05-11 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
US20070293927A1 (en) 2004-02-17 2007-12-20 The Children's Hospital Of Philadelphia Gene and Cell Delivery Self Expanding Polymer Stents
US8114431B2 (en) 2006-09-19 2012-02-14 Georgia Tech Research Corporation Biomolecular coating for implants
US8114834B2 (en) 2006-11-09 2012-02-14 Northwestern University Self-assembling peptide amphiphiles
AU2008210149B2 (en) * 2007-01-30 2011-07-14 Hemoteq Ag Biodegradable vascular support
US9237945B2 (en) * 2007-01-30 2016-01-19 University of Pittsburgh—of the Commonwealth System of Higher Education Bioerodible wraps and uses therefor
JP2008253297A (ja) * 2007-03-30 2008-10-23 Univ Kansai Medical 医療用チューブ
US8735354B2 (en) 2008-11-07 2014-05-27 Uab Research Foundation Endothelium mimicking nanomatrix

Also Published As

Publication number Publication date
CA2742782A1 (en) 2010-05-14
US20100119573A1 (en) 2010-05-13
JP5693458B2 (ja) 2015-04-01
JP2012508255A (ja) 2012-04-05
EP2365820B1 (en) 2018-10-24
WO2010054316A3 (en) 2010-07-01
KR20180125627A (ko) 2018-11-23
AU2009313243B2 (en) 2016-07-28
US8735354B2 (en) 2014-05-27
ES2699459T3 (es) 2019-02-11
AU2009313243A1 (en) 2010-05-14
WO2010054316A2 (en) 2010-05-14
EP2365820A2 (en) 2011-09-21
KR101822200B1 (ko) 2018-01-25
EP2365820A4 (en) 2013-01-16
CN102355904A (zh) 2012-02-15
KR20110096031A (ko) 2011-08-26
CA2742782C (en) 2020-02-18

Similar Documents

Publication Publication Date Title
KR101822200B1 (ko) 내피 모방 나노매트릭스
JP5777510B2 (ja) 生物適合性及び生分解性のエラストマー性ポリマー
Lin et al. Bone induction by biomimetic PLGA-(PEG-ASP) n copolymer loaded with a novel synthetic BMP-2-related peptide in vitro and in vivo
Hasirci et al. Nanobiomaterials: a review of the existing science and technology, and new approaches
US8748569B2 (en) Peptide amphiphiles and methods to electrostatically control bioactivity of the ikvav peptide epitope
JP2009102418A (ja) 医療用具をコーティングするための組成物及び方法
JP2007532510A (ja) 上昇した血中尿素濃度を低減させるオリゴペプチド
US6262017B1 (en) Peptides for altering osteoblast adhesion
Guo et al. Nanofiber scaffolds for treatment of spinal cord injury
Lee et al. Surface perspectives in the biomedical applications of poly (α-hydroxy acid) s and their associated copolymers
WO2019094734A1 (en) Decellularization and functionalization of extracellular matrix biomaterials
Song et al. Physicobiological properties and biocompatibility of biodegradable poly (oxalate‐co‐oxamide)
US20240199698A1 (en) Peptide amphiphile compositions and methods of use thereof
US20240218017A1 (en) Peptide amphiphiles with modified degrading sequences and methods of use thereof
Kushwaha Biomimetic Self-Assembled Nanomatrix for Drug Eluting Stent Application
Zorlutuna et al. Biomaterials and tissue engineering research in Turkey: The METU Biomat Center experience
Huang Engineering RGD-Modified Liposomes for Targeted Drug Delivery to Activated Platelets
Rafati The analysis of polymers for biomedical applications
Saraf Nanofibers: Peptide Amphiphile-Based

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20171012

Application number text: 1020117013015

Filing date: 20110607

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20171023

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20180820

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20171023

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I